Published online Nov 8, 2025. doi: 10.35712/aig.v6.i3.107528
Revised: April 14, 2025
Accepted: October 13, 2025
Published online: November 8, 2025
Processing time: 226 Days and 16.7 Hours
The gold standard for colorectal polyp screening is currently colonoscopy, but the miss rate is still high and the adenoma detection rate and polyp detection rate are still low. The risk factors include the patient, operators, and the tools used. The use of artificial intelligence (AI) in colonoscopy has gained popularity by assisting endoscopists in the detection and characterization of polyps.
To evaluate the diagnostic performance of AI-assisted colonoscopy [computer assisted diagnosis (CAD) eye function] for colorectal polyp characterization.
This study used a cross-sectional design conducted at the Gastrointestinal End
A total of 60 patients with 100 polyps were involved in this study. Based on the results of the examination, it was found that the AI CAD eye function examination had a sensitivity of 79.17%, specificity of 75.00%, positive pre
AI CAD eye function examination had a high sensitivity value in diminutive, sessile polyps and right-sided polyps and a high specificity in non-diminutive, non-sessile polyps and left-sided polyps.
Core Tip: Colonoscopy is currently the gold standard for screening colorectal polyps. However, the miss rate remains high, and the adenoma detection rate and polyp detection rate remain low. The risk factors included patients, operators, and the tools used. The use of artificial intelligence in colonoscopy has gained popularity because it helps endoscopists detect and characterize polyps. This cross-sectional study was conducted on adult patients with suspected colorectal polyps. The overall performance of the artificial intelligence (computer-assisted diagnosis eye function) showed a sensitivity of 79.17%, specificity of 75.00%, positive predictive value of 89.06%, negative predictive value of 58.33%, and accuracy of 78.00%.
- Citation: Asputra H, Maulahela H, Fauzi A, Rumende CM, Pitarini A, Sari NK, Shatri H. Diagnostic value of artificial intelligence computer-assisted diagnosis (computer assisted-diagnosis eye function) for colorectal polyps. Artif Intell Gastroenterol 2025; 6(3): 107528
- URL: https://www.wjgnet.com/2644-3236/full/v6/i3/107528.htm
- DOI: https://dx.doi.org/10.35712/aig.v6.i3.107528
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide[1]. Accounting for 10% of all cancer cases, it is the third-leading cause of cancer-related deaths globally[2]. The prevalence of CRC varies globally, ranging from 30 per 100000 to 40 per 100000 in the United States, 15-30 per 100000 in Europe, and less than 5-10 per 100000 in South America and Asia[3]. In Indonesia CRC cases reached 34189 in 2020[4]. CRC is the third most common cancer among both sexes[5] with a lifetime risk of approximately 6% in the United States[6]. Despite advancements in treatment the 5-year survival rate remains around 55%[7].
Colonoscopy-based screening programs are crucial for reducing mortality by enabling early diagnosis and detection of precancerous lesions. Colonoscopy can reduce CRC incidence by 70%-80%[8]. However, screening at the population level involves significant financial and economic costs[9], primarily due to histopathology costs post-polypectomy despite most resections being small polyps representing over 90% of all lesions[10]. Furthermore, long-term effectiveness of colonoscopy is influenced by various factors, including operator skill and potential complications such as bleeding, perforation, and infection[11]. Miss rates for adenomas, particularly small ones, can be significant (24%-35%)[12,13], and diagnosing small polyps is challenging due to sampling difficulties and dependence on polyp location and endoscopist experience[14]. This is consistent with interval cancer incidence, which represents cancers diagnosed after screening but before surveillance (around 3%-5%)[15].
Quality metrics in colonoscopy screening include adenoma detection rate (ADR), bowel preparation rate, cecal intubation rate, and withdrawal time. Increasing ADR by 1% can reduce CRC risk by 3%[16]. Innovations such as virtual and dye-spray chromoendoscopy, along with additional devices, can enhance ADR, particularly in low detection scenarios[17]. However, these strategies are operator-dependent and require learning time, and individual experience and preferences may affect their efficacy.
Currently, colonoscopy remains the gold standard for colorectal polyp screening, yet sensitivity has not reached 100% with high miss rates and low ADR and polyp detection rate impacting outcomes. Artificial intelligence (AI) technologies offer potential improvements in polyp detection and characterization. AI, particularly deep convolutional neural networks, has shown promise in enhancing ADR and polyp detection rate[11]. AI assists endoscopists by highlighting areas requiring closer examination and differentiating polyp types, thus potentially increasing ADR[18]. AI has dem
This study aimed to evaluate the diagnostic efficacy of the AI-based CAD system in colorectal polyp characterization, correlating findings with histopathological examination based on polyp size, location, and morphology.
This cross-sectional study evaluated the diagnostic performance of AI-assisted colonoscopy (CAD eye function) for colorectal polyp characterization. The study was conducted at the Gastrointestinal Endoscopy Center of Dr. Cipto Mangunkusumo Hospital. Data were collected from medical records and colonoscopy procedures utilizing AI (CAD eye function). Sampling occurred if colorectal polyps were detected.
The target population for this study included patients aged 18 years and older undergoing colonoscopy with AI (CAD eye function). Inclusion criteria were: Patients aged 18 or older who had risk factors for colorectal polyps and who received care at Dr. Cipto Mangunkusumo Hospital from January to May 2024. Exclusion criteria were: Incomplete medical records and a Boston bowel preparation scale score of less than 6. The sample was drawn from individuals who meet these inclusion and exclusion criteria. According to the sample size formula for descriptive categorical research, a total of 57 participants was needed.
Patients with suspected colorectal polyps who visited the Gastroenterology Clinic or were admitted to Dr. Cipto Mangunkusumo Hospital were selected for the study. After providing informed consent these patients underwent a colonoscopy using AI (CAD eye function). Detected polyps were documented in terms of their location, size, and mor
Data processing were conducted using Statistical Package for the Social Sciences 22.0. Clinical and participant characteristics were reported as mean ± SD for normally distributed data or median with range for non-normally distributed data. The Kolmogorov-Smirnov test was used to assess normality. Bivariate analysis involved χ² or Fisher's exact tests for categorical variables and t-test or Mann-Whitney test for numerical variables. The performance of AI-assisted col
The median age of subjects in this study was 61.5 years with an interquartile range of 20-76 years. The most common age group was 60-69 years, comprising 23 subjects (38.3%). Gender distribution was balanced with 30 females (50.0%) and 30 males (50.0%). Ethnically, most subjects were Javanese (28, 46.7%). Obesity was present in 12 subjects (20.0%) while 48 subjects (80.0%) were not obese. Inflammatory bowel disease was observed in 30.0% of subjects (18 individuals) with 70.0% (42 individuals) having no inflammatory history. Diabetes mellitus (DM) was reported in 12 subjects (20.0%), and 48 subjects (80.0%) were without DM. A family history of polyps was found in 8 subjects (13.3%) while 52 subjects (86.7%) had no such history. A family history of CRC was noted in 6 subjects (10.0%) with 54 subjects (90.0%) having no family history of CRC (Table 1).
| Variable | Total (n = 60) |
| Age (years), median (interquartile range) | 61.5 (20-76) |
| Age | |
| < 30 years | 4 (6.7) |
| 30-39 years | 4 (6.7) |
| 40-49 years | 6 (10.0) |
| 50-59 years | 13 (21.7) |
| 60-69 years | 23 (38.3) |
| > 70 years | 10 (16.7) |
| Gender | |
| Female | 30 (50.0) |
| Male | 30 (50.0) |
| Ethnicity | |
| Javanese | 28 (46.7) |
| Sundanese | 5 (8.3) |
| Minangkabau | 2 (3.3) |
| Batak | 9 (15.0) |
| Chinese | 9 (15.0) |
| Other | 7 (11.7) |
| Obesity | |
| Yes | 12 (20.0) |
| No | 48 (80.0) |
| Inflammatory bowel disease | |
| Yes | 18 (30.0) |
| No | 42 (70.0) |
| Diabetes mellitus | |
| Yes | 12 (20.0) |
| No | 48 (80.0) |
| Family history of polyps | |
| Yes | 8 (13.3) |
| No | 52 (86.7) |
| Family history of colorectal cancer | |
| Yes | 6 (10.0) |
| No | 54 (90.0) |
Most polyps measured 1-5 mm in size, accounting for 56% of the cases. Larger polyps, specifically those ≥ 10 mm were less frequent (just 33%), and only 11% of polyps fell into the 6-9 mm size range. The predominant location for polyps was the rectosigmoid region with 51% of polyps found there. The next most common locations were the ascending colon (19%), descending colon (17%), transverse colon (8%), and cecum (5%). In terms of morphology sessile polyps were the most prevalent, comprising 75% of the samples, followed by pedunculated polyps at 16%, and semipedunculated polyps at 9% (Table 2).
| Variable | Total (n = 100) |
| Polyp size | |
| 1-5 mm | 56 (56) |
| 6-9 mm | 11 (11) |
| ≥ 10 mm | 33 (33) |
| Polyp location | |
| Rectosigmoid polyp | 51 (51) |
| Descending colon polyp | 17 |
| Transverse colon polyp | 8 (8) |
| Ascending colon polyp | 19 (19) |
| Cecum polyp | 5 |
| Morfologi polyp | |
| Sessile polyp | 75 |
| Semipedunculated polyp | 9 (9) |
| Pedunculated polyp | 16 (16) |
| Flat polyp | 0 (0) |
| Other polyp | 0 (0) |
Based on the study results, the overall performance of AI (CAD eye function) showed a sensitivity of 79.17%, specificity of 75.00%, positive predictive value (PPV) of 89.06%, negative predictive value (NPV) of 58.33%, and accuracy of 78.00% as detailed in Table 3.
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 57 | 7 | 64 |
| Neoplastic | 15 | 21 | 36 | |
| Total | 72 | 28 | 100 | |
| Sensitivity (%) | 79.17 | |||
| Specificity (%) | 75.00 | |||
| Positive predictive value (%) | 89.06 | |||
| Negative predictive value (%) | 58.33 | |||
| Accuracy | 78.00 | |||
For diminutive polyps, which are 1-5 mm in size, CAD eye function demonstrated a high sensitivity of 86.27%, but a lower specificity of 60.00% with a PPV of 95.65% and a NPV of 30.00%, resulting in an accuracy of 83.93% (Table 4). Conversely, for non-diminutive polyps, which are larger than 5 mm, the sensitivity was lower at 61.90%, but the specificity was higher at 78.26% with a PPV of 72.22% and an NPV of 69.23%, leading to an accuracy of 70.45% as detailed in Table 5.
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 44 | 2 | 46 |
| Neoplastic | 7 | 3 | 10 | |
| Total | 51 | 5 | 56 | |
| Sensitivity (%) | 86.27 | |||
| Specificity (%) | 60.00 | |||
| Positive predictive value (%) | 95.65 | |||
| Negative predictive value (%) | 30.00 | |||
| Accuracy | 83.93 | |||
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 13 | 5 | 18 |
| Neoplastic | 8 | 18 | 26 | |
| Total | 21 | 23 | 44 | |
| Sensitivity (%) | 61.90 | |||
| Specificity (%) | 78.26 | |||
| Positive predictive value (%) | 72.22 | |||
| Negative predictive value (%) | 69.23 | |||
| Accuracy | 70.45 | |||
Detecting left-sided colon polyps showed a sensitivity of 78.85%, specificity of 81.25%, PPV of 93.18%, NPV of 54.17%, and accuracy of 79.41% (Table 6). In contrast, for right-sided colon polyps, the sensitivity was 80.00%, specificity was 66.67%, PPV was 80.00%, NPV was 66.67%, and accuracy was 75.00% (Table 7).
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 41 | 3 | 44 |
| Neoplastic | 11 | 13 | 24 | |
| Total | 52 | 16 | 68 | |
| Sensitivity (%) | 78.85 | |||
| Specificity (%) | 81.25 | |||
| Positive predictive value (%) | 93.18 | |||
| Negative predictive value (%) | 54.17 | |||
| Accuracy | 79.41 | |||
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 16 | 4 | 20 |
| Neoplastic | 4 | 8 | 12 | |
| Total | 20 | 12 | 32 | |
| Sensitivity (%) | 80.00 | |||
| Specificity (%) | 66.67 | |||
| Positive predictive value (%) | 80.00 | |||
| Negative predictive value (%) | 66.67 | |||
| Accuracy | 75.00 | |||
For sessile polyps CAD eye function demonstrated a sensitivity of 81.54%, specificity of 50.00%, PPV of 91.38%, NPV of 29.41%, and accuracy of 77.33% when compared with the gold standard (histopathology) (Table 8). Conversely, for non-sessile polyps the sensitivity was lower at 57.14%, but the specificity was higher at 88.89%, with a PPV of 66.67% and an NPV of 84.21%, resulting in an accuracy of 80.00% as detailed in the Table 9.
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 53 | 5 | 58 |
| Neoplastic | 12 | 5 | 17 | |
| Total | 65 | 10 | 75 | |
| Sensitivity (%) | 81.54 | |||
| Specificity (%) | 50.00 | |||
| Positive predictive value (%) | 91.38 | |||
| Negative predictive value (%) | 29.41 | |||
| Accuracy | 77.33 | |||
| Examination result | Histopathology | |||
| Hyperplastic | Neoplastic | Total | ||
| Computer-assisted diagnosis eye | Hyperplastic | 4 | 2 | 6 |
| Neoplastic | 3 | 16 | 19 | |
| Total | 7 | 18 | 25 | |
| Sensitivity (%) | 57.14 | |||
| Specificity (%) | 88.89 | |||
| Positive predictive value (%) | 66.67 | |||
| Negative predictive value (%) | 84.21 | |||
| Accuracy | 80.00 | |||
Colonoscopy using AI CAD eye function showed good performance in diagnosing colorectal polyps. Based on the results, the sensitivity and specificity of CAD eye function in detecting hyperplastic polyps were 79.17% and 75.00%, respectively. The PPV of 89.06% and NPV of 58.33% showed that the method was quite reliable in identifying hyperplastic and neoplastic polyps. This indicates good diagnostic value. AI has advantages over histopathology in terms of diagnostic speed time. AI can determine polyp characteristics within moments while histopathology takes 1-2 weeks. Histopa
Polyp size: Based on size, diminutive polyps (≤ 5 mm) had a sensitivity of 86.27%, specificity of 60.00%, PPV of 95.65%, NPV of 30.00%, and accuracy of 83.93%. Meanwhile, non-diminutive polyps (> 5 mm) showed a sensitivity of 61.90%, specificity of 78.26%, PPV of 72.22%, NPV of 69.23%, and accuracy of 70.45%. This may be due to the fact that AI (CAD eye function) observation of large polyps did not cover all polyp surfaces. Only the edges of the polyps and large polyps in the subjects of this study were mostly pedunculated polyps, which are generally mobile, making it difficult for AI to characterize perfectly. It is suggested to develop AI with more specific features for large polyps.
Polyp morphology: Non-sessile polyps had a sensitivity of 57.14%, specificity of 88.89%, PPV of 66.67%, NPV of 84.21%, and accuracy of 80.00% while sessile polyps showed a sensitivity of 81.54%, specificity of 50.00%, PPV of 91.38%, NPV of 29.41%, and accuracy of 77.33%. In this study it was found that non-sessile polyps had low sensitivity, likely due to the fact that the majority of non-sessile polyps in this study were pedunculated and semipedunculated polyps, which have a larger size and are mobile, so that the CAD eye function cannot cover the entire surface of the polyp and because it is mobile, making it difficult for AI to characterize perfectly. Sessile polyps have low specificity that may be due to the fact that AI only assesses the surface of the polyp while the neoplastic process starts from the submucosa, which is not assessed by AI.
Polyp location: On the left side of the colon, the sensitivity was recorded at 78.85%, specificity of 81.25%, PPV of 93.18%, NPV of 54.17%, and accuracy of 79.41%. Meanwhile, on the right side of the colon, the sensitivity reached 80.00%, specificity of 66.67%, PPV of 80.00%, NPV of 66.67%, and accuracy of 75.00%. This is because the anatomy and structure of the right colon have fewer folds and is more fixed, making it easier for AI to characterize polyps while the left side has many folds and is not fixed.
The limitation of this study was that the input data used by AI needed to be varied to improve sensitivity and specificity. AI also has limitations in large and mobile object features.
With future data variations, it is expected to increase its sensitivity and specificity on large and moving objects. As of now histopathology examination is still the gold standard and reference for data input to AI.
This study was the first to thoroughly explore the diagnostic capabilities of AI on colorectal polyp characteristics. To further explore the application of AI, it is recommended that there be a cost-effective study between AI and histopa
Colonoscopy with the AI CAD eye function demonstrates overall good diagnostic value and can be used to improve the characteristics of colorectal polyps. AI CAD eye function examination has a high sensitivity value in diminutive, sessile polyps and right-sided colon and high specificity in non-diminutive, non-sessile and left-sided colon. Histopathology is still the gold standard to evaluate the result of the AI. Therefore, AI can improve the future result and enhance the sensitivity and specificity.
| 1. | Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 53206] [Cited by in RCA: 56211] [Article Influence: 8030.1] [Reference Citation Analysis (132)] |
| 2. | Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 687] [Cited by in RCA: 1441] [Article Influence: 360.3] [Reference Citation Analysis (5)] |
| 3. | Floch MH, Pitchumoni CS, Floch NR, Rosenthal R, Scolapio J, Lim JK. Netter's Gastroenterology. 3rd Edition. Netherlands: Elsevier, 2019. |
| 4. | Sanjaya IWB, Lestarini A, Bharata MDY. Clinical Characteristics of Colorectal Cancer Patients Undergoing Colonoscopy at Sanjiwani Hospital, Gianyar, 2019-2020. AMJ. 2023;3:43-48. [DOI] [Full Text] |
| 5. | World Health Organization. The World health report: 1997: Conquering suffering, enriching humanity/report of the Director-General. 1997. Available from: https://iris.who.int/items/478ac0a5-2965-4ac2-82c4-2b7913d59057. |
| 6. | Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C, Runowicz C, Saslow D, Cokkinides V, Eyre H; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin. 2001;51:38-75; quiz 77. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 541] [Cited by in RCA: 509] [Article Influence: 21.2] [Reference Citation Analysis (0)] |
| 7. | Bond JH, Levin B. Screening and surveillance for colorectal cancer. Am J Manag Care. 1998;4:431-437. |
| 8. | Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med. 1995;123:904-910. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 394] [Cited by in RCA: 367] [Article Influence: 12.2] [Reference Citation Analysis (0)] |
| 9. | Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupé VMH. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis. Ann Intern Med. 2017;167:544-554. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 46] [Cited by in RCA: 54] [Article Influence: 6.8] [Reference Citation Analysis (0)] |
| 10. | Gupta N, Bansal A, Rao D, Early DS, Jonnalagadda S, Wani SB, Edmundowicz SA, Sharma P, Rastogi A. Prevalence of advanced histological features in diminutive and small colon polyps. Gastrointest Endosc. 2012;75:1022-1030. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 124] [Cited by in RCA: 151] [Article Influence: 11.6] [Reference Citation Analysis (0)] |
| 11. | Dominitz JA, Eisen GM, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Faigel DO; Standards of Practice Committee. American Society for Gastrointestinal Endoscopy. Complications of colonoscopy. Gastrointest Endosc. 2003;57:441-445. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 126] [Cited by in RCA: 117] [Article Influence: 5.3] [Reference Citation Analysis (0)] |
| 12. | Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, Sautereau D, Boustière C, Grimaud JC, Barthélémy C, Sée J, Serraj I, D'Halluin PN, Branger B, Ponchon T. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy. 2008;40:284-290. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 351] [Cited by in RCA: 375] [Article Influence: 22.1] [Reference Citation Analysis (0)] |
| 13. | Kim NH, Jung YS, Jeong WS, Yang HJ, Park SK, Choi K, Park DI. Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies. Intest Res. 2017;15:411-418. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 48] [Cited by in RCA: 78] [Article Influence: 9.8] [Reference Citation Analysis (0)] |
| 14. | Jung DK, Kim TO, Kang MS, Kim MS, Kim MS, Moon YS. The Colonoscopist's Expertise Affects the Characteristics of Detected Polyps. Clin Endosc. 2016;49:61-68. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 4] [Cited by in RCA: 6] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 15. | Singh S, Singh PP, Murad MH, Singh H, Samadder NJ. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1375-1389. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 228] [Cited by in RCA: 217] [Article Influence: 19.7] [Reference Citation Analysis (0)] |
| 16. | Ertem FU, Ladabaum U, Mehrotra A, Tehranian S, Shi Z, Saul M, Morris M, Crockett SD, Schoen RE. Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice. Gastrointest Endosc. 2018;88:705-711.e1. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 17] [Cited by in RCA: 22] [Article Influence: 3.1] [Reference Citation Analysis (0)] |
| 17. | Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 75126] [Cited by in RCA: 66279] [Article Influence: 16569.8] [Reference Citation Analysis (183)] |
| 18. | Ebigbo A, Mendel R, Probst A, Manzeneder J, Prinz F, de Souza LA Jr, Papa J, Palm C, Messmann H. Real-time use of artificial intelligence in the evaluation of cancer in Barrett's oesophagus. Gut. 2020;69:615-616. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 84] [Cited by in RCA: 127] [Article Influence: 25.4] [Reference Citation Analysis (0)] |
| 19. | Hoerter N, Gross SA, Liang PS. Artificial Intelligence and Polyp Detection. Curr Treat Options Gastroenterol. 2020;18:120-136. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 28] [Cited by in RCA: 29] [Article Influence: 5.8] [Reference Citation Analysis (0)] |
| 20. | Bisschops R, East JE, Hassan C, Hazewinkel Y, Kamiński MF, Neumann H, Pellisé M, Antonelli G, Bustamante Balen M, Coron E, Cortas G, Iacucci M, Yuichi M, Longcroft-Wheaton G, Mouzyka S, Pilonis N, Puig I, van Hooft JE, Dekker E. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019. Endoscopy. 2019;51:1155-1179. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 152] [Cited by in RCA: 242] [Article Influence: 40.3] [Reference Citation Analysis (1)] |
| 21. | Vulcan A, Manjer J, Ohlsson B. High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study. BMC Cancer. 2017;17:842. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 19] [Cited by in RCA: 35] [Article Influence: 4.4] [Reference Citation Analysis (1)] |
